Skip to main content
. 2014 Mar 30;2014(3):CD005195. doi: 10.1002/14651858.CD005195.pub3
Study Reason for exclusion
Bostick 1993 Cohort study: Iowa Women's Health Study cohort
Selenium exposure not assessed according to eligibility: only intake of selenium supplements yes/no in questionnaire assessed
Brock 1991 Case‐control study with precancerous condition (carcinoma in situ of the cervix)
Chen 1988 Case‐control study
Chen 2003 Case‐control study
Connelly‐Frost 2009 Case‐control study
Costello 2001 APPOSE (Australian Prostate Cancer Prevention Trial Using Selenium): publication describes study design, trial was not started
Criqui 1991 Population‐based prospective case‐control study: Lipid Research Clinic Prevalence and Follow‐Up study
Results not reported according to inclusion criteria: differences in mean selenium levels reported
Cui 2007 Nested case‐control study
Selenium exposure not assessed according to eligibility: selenium measurement conducted in tissue of benign breast disease
Davies 2002 Nested case‐control study: EPIC Norfolk study cohort
Results not reported according to inclusion criteria: RR estimate per unit increase in selenium level reported
Fleshner 2003 Randomised Study of Vitamin E, Selenium, and Soy Protein Isolate in Patients with High‐Grade Prostatic Intraepithelial Neoplasia:
Multicomponent Intervention
Hagmar 1992 Historical cohort study
Harris 2012 Cancer was not a study endpoint
Hartman 2002 Nested case‐control study: ATBC cohort
Results not reported according to inclusion criteria: differences in mean selenium levels reported; OR reported as graph and could not be calculated from reported data
Huzarski 2006 Interventional study without control group with 1489 female participants with BRCA1 mutation who received a selenium‐containing nutritional supplement
Joniau 2007 Intervention study without control group with male participants with high‐grade intraepithelial neoplasia of the prostate who received a selenium‐containing nutritional supplement
Kellen 2008 Case‐control study
Kilander 2001 Cohort study in Uppsala/Sweden
Results not reported according to inclusion criteria: RR estimate per unit increase in selenium level reported
Knekt 1988a Nested case‐control study: Mobile Health Clinic cohort
Results not reported according to inclusion criteria: differences in mean selenium levels reported
Knekt 1988b Nested case‐control study: Mobile Health Clinic cohort
Results not reported according to inclusion criteria: differences in mean selenium levels reported
Knekt 1991 Nested case‐control study: Mobile Health Clinic cohort
Results not reported according to inclusion criteria: differences in mean selenium levels reported
Kok 1987b Nested case‐control study: Zoetermeer cohort
Results not reported according to inclusion criteria: differences in mean selenium levels reported
Kune 2006 Case‐control study
Kuroda 1988 Case‐control study
Lawson 2007 Cohort study on multivitamin use and risk of prostate cancer
Le Marchand 2006 Case‐control study
Li 2004b RCT for gastric cancer prevention with multicomponent intervention (200 mg synthetic allitridum and 100 μg selenium per day)
Limburg 2005 Randomised controlled trial: primary endpoint in this two‐by‐two factorial design trial with selenomethionine 200 µg daily and/or celecoxib 200 mg twice daily was the per‐participant change (regression, stable, progression) of preexisting oesophageal dysplasia—cancer incidence and mortality were not endpoints in this study
Linxian Pilot 2000 Randomised controlled trial with selenium supplements and celecoxib in participants with oesophageal squamous dysplasia in Linxian, China
Endpoint was "regression of disease", cancer was not an endpoint in this investigation
Neuhouser 2009 Cohort study (Women's Health Initiative) on multivitamin use and risk of cancer and cardiovascular disease
No data for selenium and cancer risk reported
Ray 2006 Cohort study (Women's Health and Aging Studies I and II) on selenium and carotenoid serum levels and mortality
No data for selenium and cancer mortality reported
Rayman 2001 PRECISE trial (Prevention of Cancer by Intervention with Selenium): trial has been stopped
Rendon Randomised controlled trial: Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients with High‐Grade Prostate Neoplasia: Multicomponent Intervention
Steevens 2010b Cancer was not a study endpoint
Thompson 2009 Cohort study: Iowa Women's Health Study cohort
Selenium exposure not assessed according to eligibility: only intake of selenium supplements yes/no in questionnaire assessed
Tsugane 1996 Case‐control and cross‐sectional studies
Ujiie 2002 A part of this study is a prospective cohort study in Miyagi/Japan
Results not reported according to inclusion criteria: differences in mean selenium levels reported
van Noord 1992 Nested case‐control study: DOM cohort
Results not reported according to inclusion criteria: differences in mean selenium levels reported
van Noord 1993 Nested case‐control study: DOM II cohort
Results not reported according to inclusion criteria: RR estimate per unit increase of selenium level reported
van't Veer 1996 Case‐control study
Wallace 2009 Case‐control study
Watters 2009 Cohort study on smoking and prostate cancer risk. Selenium not reported as independent variable
Wright 2004 Cohort study: ATBC cohort
Exposure to antioxidants was assessed using a self‐developed index
You 2005 Randomised controlled trial to test retardation of the progression of precancerous gastric lesions among 3400 adults in Shandong, China. Intervention: vitamin C, vitamin E, selenium, garlic preparation
Multicomponent intervention
Yuan 2006 Nested case‐control study: Shanghai cohort study
No data on selenium and cancer risk reported
Zeegers 2009 Cohort study on factors influencing recurrence or progression of bladder cancer: West Midlands Bladder Cancer Prognosis Programme

µ = micro

APPOSE = Australian Prostate Cancer Prevention Trial Using Selenium ATBC = alpha‐tocopherol, beta‐carotene cancer prevention study BRCA = breast cancer DOM = Diagnostic Onderzoek Mammacarcinoom EPIC = European Prospective Investigation of Cancer m = milli g = gram

OR = odds ratio PRECISE = Prevention of Cancer by Intervention with Selenium RCT = randomised controlled trial